OpenAI acquires a drug-development operations company, pushing AI into real science workflows
aitrendz_xyz · x · 2026-10-21
OpenAI has acquired a company that helps run drug development operations, aiming to embed AI into the actual process of discovering and testing new medicines — a signal, the author argues, that AI's real money and impact are moving from email and code into science and real work.
Related event: OpenAI Acquires Orchestra Bio to Bring AI Agents into Drug Development(18 posts)→
More from Companies & People
- EPFL expands CS faculty hiring with openings in security, math of learning and AI alignment — caglarml · 2026-10-21
- Jensen Huang spent 10 keynote minutes telling microducks to sit before Nvidia's roadmap — Thom_Wolf · 2026-10-21
- OpenAI DevDay community hackathon hits London Nov 1 with ChatGPT Pro prizes — paw_lean · 2026-10-21
- OpenAI DevDay heads to Paris with hackathon, finale, and three tracks — paw_lean · 2026-10-21
- First OpenAI Codex Community Meetup in Brighton draws lively demos — paw_lean · 2026-10-21
- NHS to Roll Out Copilot to 500,000 Staff, Starting with Yorkshire Ambulance — satyanadella · 2026-10-21